Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04722523
Title A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications

hypopharynx cancer

nasal cavity cancer

laryngeal squamous cell carcinoma

paranasal sinus cancer

oropharynx cancer

head and neck squamous cell carcinoma

oral squamous cell carcinoma

Therapies

Cemiplimab + Cetuximab + Cisplatin + Docetaxel

Carboplatin + Cemiplimab + Cetuximab + Docetaxel

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.